Cat-pad clinical trials
How each study uses cat-pad is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Cat-PAD
- 9
Studies by the year they started
9 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
Who runs them
Industry 8 · Other 1
Circassia Limited (8) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Studies
Open first, then newest update. How each study uses cat-pad is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- A Randomized Prospective Clinical Trial of Fel d 1 Peptide ImmunotherapyCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT02311413Written as Cat-PAD
- Phase III Cat-PAD StudyCompletedPhase 3Circassia LimitedNCT01620762Written as Cat-PAD
- Paediatric Safety Study in Cat-PADCompletedPhase 2Circassia LimitedNCT01921257Written as Cat-PAD
- Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array AnalysisCompletedPhase 1Circassia LimitedNCT01383603Written as Cat-PAD
- Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics AnalysisCompletedPhase 1Circassia LimitedNCT01383590Written as Cat-PAD
- Cat-PAD Exposure Chamber StudyCompletedPhase 2Circassia LimitedNCT01033344Written as Cat-PAD
- Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled AsthmaCompletedPhase 2Circassia LimitedNCT00867906Written as Cat-PAD
- Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic SubjectsCompletedPhase 2Circassia LimitedNCT00729508Written as Cat-PAD
- Safety of Cat-PAD in Cat Allergic SubjectsCompletedPhase 1/2Circassia LimitedNCT00685711Written as Cat-PAD